Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Repaglinide (0.5mg) Tablet
Therapeutic Category
Antidiabetic, Diabetic, Endocrinology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Repohike Tablet (Repaglinide 0.5mg) is a high-profit, essential chronic care product built for our PCD Pharma Franchise partners.
This tablet contains Repaglinide, an effective oral anti-diabetic agent used to help Type 2 Diabetes patients manage their post-meal blood sugar levels. Given the lifelong nature of diabetes management, this product guarantees stable, consistent monthly refills and provides exceptional financial stability.
Why Repohike is Your Key to Profit:
Guaranteed Recurring Revenue: Diabetes management requires daily, long-term medication. Repaglinide ensures consistent, predictable monthly refills and superior financial stability from the massive chronic care patient base.
Excellent Chronic Care Margin: Positioned as an essential drug in the high-volume metabolic segment, this product commands competitive pricing while securing superior profit margins due to guaranteed patient loyalty and stable demand.
Physician Loyalty: The proven efficacy and specific role of Repaglinide in managing mealtime glucose spikes build strong, reliable prescription loyalty from endocrinologists and general practitioners.
Monopoly Opportunity: We offer exclusive rights for your area—meaning zero competition for this essential chronic care formulation. Partner with us for full marketing support to secure high-value, recurring prescriptions and guaranteed business growth.
Contact us today to capture this max-margin chronic care segment!
Some patients may experience hypoglycemia, mild gastrointestinal discomfort, nausea, or headache. Rarely, allergic reactions or significant drops in blood sugar levels may occur and require immediate medical attention.
Repohike 0.5 Tablet is indicated for the management of type 2 diabetes mellitus in adults, especially for controlling post-meal hyperglycemia. It helps maintain stable blood glucose levels, reduces the risk of diabetes-related complications, and can be used alone or in combination with other antidiabetic medications as part of a comprehensive diabetes management plan.
Sodium Hyaluronate is generally well-tolerated. Mild side effects may include temporary blurred vision, slight stinging, or a watery sensation after instillation. Allergic reactions are rare but may present as redness, itching, or swelling. If persistent discomfort occurs, consult an ophthalmologist.
Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Composition : Thiocolchicoside IP 4mg + Paracetamol IP 325mg Tablet
Composition : Thiocolchicoside 8mg + Paracetamol 325mg Tablet
Composition : Paracetamol 650mg + Caffeine 50mg Tablet
Composition : Caffeine (30mg) + Diphenhydramine (25mg) + Paracetamol (500mg) + Phenylephrine (5mg)
Composition : Mefenamic Acid (500mg) + Paracetamol (325mg)
Composition : Domperidone I.P. 10mg + Paracetamol I.P. 325mg
Composition : Paracetamol (650mg)
Composition : Paracetamol (I.R.) 300mg + Paracetamol (S.R.) 700mg
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Repaglinide 0.5mg Tablet has strong demand in the anti-diabetic and metabolic care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on diabetes management portfolios.
Medical distributors and agencies can benefit from consistent demand for management of Type 2 Diabetes Mellitus and post-meal (postprandial) blood sugar control. Repaglinide 0.5mg is a short-acting insulin secretagogue that helps control blood sugar spikes after meals Commonly used in oral anti-diabetic therapy under physician supervision This strengthens a reliable diabetes-care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Repaglinide 0.5mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong physician prescriptions, targeted postprandial glucose control demand, long-term diabetic patient usage, reliable supply chain support, and good margins in anti-diabetic medicines.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.